Veradigm | MDRX - Assets


Veradigm reported $1.5B in Assets for its fiscal quarter ending in December of 2022.





Assets Change Date
Alcidion AUD 118.08M 2.46M Dec/2025
Ambu A/S DKK 8.22B 449M Sep/2026
Amplifon EUR 3.6B 328.33M Jun/2026
Cardinal Health USD 59.54B 2.24B Sep/2026
Centene USD 79.28B 3.73B Sep/2026
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Cigna USD 157.64B 562M Sep/2026
Coloplast 48.8B 429M Dec/2025
Convatec Group USD 3.52B 109.3M Dec/2024
CVS Health USD 258.08B 4.31B Sep/2026
Diasorin EUR 2.9B 26.83M Jun/2026
Elevance Health USD 127.8B 1.36B Sep/2026
General Electric Aerospace USD 127.2B 477M Sep/2026
Gulf Medical Proj AED 1.55B 700K Mar/2026
Humana USD 57.28B 89M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Laboratory Of America USD 18.92B 392.3M Sep/2026
Max Healthcare Institute Limited 187.22B 14.91B Sep/2026
Maximus USD 4.37B 127.6M Jun/2026
McKesson USD 92.32B 3.99B Sep/2026
Med Life RON 3.34B 76.39M Mar/2026
Molina Healthcare USD 15.65B 351M Sep/2026
Omnicell USD 2.06B 57.98M Sep/2026
Oriola-kd EUR 771.9M 24.6M Sep/2026
Owens Minor USD 2.08B 28.5M Sep/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Rede D'or Sao Luiz BRL 113.99B 758.28M Sep/2026
Siemens Healthineers EUR 46.71B 962M Sep/2026
Sonova Holding CHF 5.92B 468.2M Jun/2025
Supermax Corporation Bhd MYR 4.27B 146.48M Jun/2026
UnitedHealth USD 312.78B 3.06B Sep/2026
Veeva Systems USD 9.06B 69.33M Jun/2026
Veradigm USD 1.5B 185.94M Dec/2022
Xerox USD 8.64B 1.08B Sep/2026